Industry Analysis
Why Big Pharma Keeps Buying Smaller Drug Brands
AbbVie spent $63 billion on Allergan. Pfizer spent $43 billion on Seagen. Why do pharmaceutical giants keep acquiring smaller companies? The answer lies in the patent cliff.
Who Brands StaffJan 30, 2026 pharmaceuticalacquisitionshealthcare
